Tetsuomi Takano, President and CEO, t2T Healthcare Inc., has been appointed as an expert (specialist) for the MEDISO program —-Medical Innovation Support Office, a comprehensive support program for medical ventures, academia, and individuals intending to put into practical use medicines, medical devices, and regenerative medicinal products—- led by the Ministry of Health, Labour and Welfare (MHLW) for fiscal year 2025 (April 1, 2025 to March 31, 2026).

MEDISO Program Portal Site

https://mediso.mhlw.go.jp/supporter/?en=1